Another Study Confirms COVID Vaccine Alters Menstrual Cycles

A study published in the BMJ Medicine in August 2022 involving almost 20,000 women found an association between those who received a COVID-19 shot and an increased length in menstrual cycles. Of the 15,000 vaccinated women in the study, two-thirds received Pfizer/BioNTech’s COVID messenger RNA (mRNA) biologic, but the data also included women who received […]
Organ Transplant Failures After COVID Vaccination

In 2022, researchers have published articles in the medical literature reporting organ transplant failures in people who have recently received COVID-19 shots. These reports include corneal graft rejections and solid organ transplant failures involving the kidneys, livers, lungs, hearts and pancreas. A study by Japanese researchers published in June in the Journal of Clinical Medicine […]
German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions

Techniker Krankenkasse, Germany’s largest health insurance company, reported that 437,593 of 11 million (1 in 25) insured individuals in 2021 had to undergo medical treatment as a result of adverse reactions from COVID-19 shots.1 COVID shots currently approved for use in Germany include Novavax’s Nuvaxovid, Moderna’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s Ad26.COV2.S, AstraZeneca/Oxford University’s […]
Vaccine Damage Claims Related to COVID Vaccinations Reach $146 Million in U.K.

Some 920 applications have been filed in the United Kingdom for compensation related to injuries and deaths of people following COVID-19 vaccinations. Those applications are for financial payouts under the U.K. National Health Service’s (NHS) Vaccine Damage Payment Scheme (VDPS), which allows an individual who has allegedly been left severely disabled by a vaccine to […]
Pfizer Withdraws EUA Application for COVID Shot in India After Regulator Asks for Independent Safety Study

Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]
Novavax’s Protein COVID-19 Vaccine Now Available in Europe

Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine has been authorized for distribution in the European Union (E.U.), making it the fifth COVID vaccine available for use in the E.U. Approved for people over 18 years old, Nuvaxoid is the first protein subunit COVID vaccine to be approved for use.1 2 The […]